ArticleThoracic cancer2023

Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first-line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2021-01).

Shinya Uematsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.